These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 24375608)

  • 1. ASHP guidelines on compounding sterile preparations.
    American Society of Health System Pharmacists
    Am J Health Syst Pharm; 2014 Jan; 71(2):145-66. PubMed ID: 24375608
    [No Abstract]   [Full Text] [Related]  

  • 2. ASHP Guidelines on Outsourcing Sterile Compounding Services.
    Am J Health Syst Pharm; 2015 Oct; 72(19):1664-75. PubMed ID: 26386108
    [No Abstract]   [Full Text] [Related]  

  • 3. Draft guidelines on compounding of nonsterile products in pharmacies. American Society of Hospital Pharmacists.
    Am J Hosp Pharm; 1993 Jul; 50(7):1452-61. PubMed ID: 8362883
    [No Abstract]   [Full Text] [Related]  

  • 4. ASHP technical assistance bulletin on compounding nonsterile products in pharmacies. American Society of Hospital Pharmacists.
    Am J Hosp Pharm; 1994 Jun; 51(11):1441-8. PubMed ID: 7942879
    [No Abstract]   [Full Text] [Related]  

  • 5. Draft guidelines on quality assurance for pharmacy-prepared sterile products.
    Am J Hosp Pharm; 1992 Feb; 49(2):407-17. PubMed ID: 1554008
    [No Abstract]   [Full Text] [Related]  

  • 6. National survey of quality assurance activities for pharmacy-compounded sterile preparations.
    Morris AM; Schneider PJ; Pedersen CA; Mirtallo JM
    Am J Health Syst Pharm; 2003 Dec; 60(24):2567-76. PubMed ID: 14735774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compounding parenteral nutrition: reducing the risks.
    Curtis C; Sacks GS
    Nutr Clin Pract; 2009; 24(4):441-6. PubMed ID: 19605798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality assurance for pharmacy-prepared sterile products in hospitals and home infusion facilities.
    Klein C
    Am J Health Syst Pharm; 1996 Nov; 53(21):2581. PubMed ID: 8913385
    [No Abstract]   [Full Text] [Related]  

  • 9. End-preparation assessments and tests for compounded sterile preparations.
    McElhiney LF
    Int J Pharm Compd; 2013; 17(4):307-11. PubMed ID: 24261146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASHP invitational conference on quality assurance for pharmacy-prepared sterile products.
    Am J Hosp Pharm; 1991 Nov; 48(11):2391-7. PubMed ID: 1746572
    [No Abstract]   [Full Text] [Related]  

  • 11. The Medicines Act 1968--its impact on the hospital pharmacist in relation to sterile products.
    Sprake JM
    Hosp Eng; 1978 Oct; 32(8):24-7. PubMed ID: 10239209
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations.
    Trissel LA; Gentempo JA; Saenz LM; Woodard MY; Angeles CH
    Am J Health Syst Pharm; 2007 Apr; 64(8):837-41. PubMed ID: 17420200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiologic Testing for 503A Sterile-Compounding Pharmacies.
    Mixon W; Roth A
    Int J Pharm Compd; 2017; 21(3):193-203. PubMed ID: 28557780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding.
    Ligugnana R
    Int J Pharm Compd; 2017; 21(3):182-190. PubMed ID: 28557779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of sterile product compounding practices in Canadian hospital pharmacies.
    Fitch DP; Hall KW
    Can J Hosp Pharm; 1993 Dec; 46(6):249-60. PubMed ID: 10131343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bacteriological quality of air in a ward for sterile pharmaceutical preparations].
    Caorsi P B; Sakurada Z A; Ulloa F MT; Pezzani V M; Latorre O P
    Rev Chilena Infectol; 2011 Feb; 28(1):14-8. PubMed ID: 21526280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals and home infusion facilities--1995.
    Santell JP; Kamalich RF
    Am J Health Syst Pharm; 1996 Nov; 53(21):2591-605. PubMed ID: 8913388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respecting the risks of sterile compounding.
    Thompson RW; Belisle C
    Am J Health Syst Pharm; 2015 Aug; 72(15):1269. PubMed ID: 26195651
    [No Abstract]   [Full Text] [Related]  

  • 19. Needed: serious attention to sterile products.
    Myers CE
    Am J Health Syst Pharm; 1996 Nov; 53(21):2582. PubMed ID: 8913386
    [No Abstract]   [Full Text] [Related]  

  • 20. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.